University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 20 of 27
Simulated Screening Study for Breast Imaging
NCT01807754
Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer
NCT01844479
Enhancing Informal Caregiving to Support Diabetes Self-Management
NCT01684709
The Effect of Immediate Implant Placement and Provisionalization in the Esthetic Zone
NCT02021331
Predicting Caries Risk in Underserved Toddlers in Primary Healthcare Settings
NCT01707797
Ultrasound Based Acoustic Radiation Force Impulse Imaging
NCT01781208
Hydronephrosis ARFI Study
NCT01781845
Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.
NCT01703663
Choline PET/CT and MRI for Targeted Prostate Biopsy
NCT01751737
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
NCT01679197
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973
Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures
NCT01673087
Improving the Self-Efficacy of African American Parents in Infant Supine Sleep
NCT01707173
Bladder ARFI (Acoustic Radiation Force Impulse) Study
NCT01781832
A Clinical Study to Compare Two Revascularization Protocols to Treat Non-vital Teeth With Incomplete Root Formation
NCT01827098
Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)
NCT01942395
Volume,Sodium and Blood Pressure Management in HD
NCT01766882
Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema
NCT02088229
Ventilation Strategies, Anesthetic Techniques and Cerebral Oxygenation in the Beach Chair Position
NCT01535274
Ultrasound Stiffness Imaging in Crohn's Disease
NCT01666626
Management of Recurrent Croup
NCT01748162
Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease
NCT01676766
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
NCT01620775
Improving Transition Outcomes Through Accessible Health IT and Caregiver Support
NCT01672385
Minimally Invasive Cardiac Output Monitoring Device
NCT01675063
Trial of the CarePartner Program for Improving the Quality of Transition Support
NCT01672398
A Clinical Trial to Prevent New Onset Diabetes After Transplantation
NCT01683331
Glaucoma Biomarkers
NCT01677507
Cell Therapy for Craniofacial Bone Defects
NCT01616953
A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain
NCT01675050
Wound Vac Bandage Comparison After Spinal Fusion
NCT03000010
Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives
NCT01612338
A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
NCT01630798
Comparing the Effectiveness of 2 Diets for Patients With Irritable Bowel Syndrome
NCT01624610
Hemodynamic Comparison of Tissue Aortic Valves
NCT01635244
Guided Bone Regeneration Around Immediate Implants
NCT01628367
Behavioral Differences in Effortful Control
NCT01852344
In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes
NCT01629290
Hepcidin and Anemia in Trauma
NCT01580267
Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer
NCT01840137
Tissue-Specific Metabolic Reprogramming in Diabetic Complications
NCT01823406
Decision Aid to Technologically Enhance Shared Decision Making
NCT01514786
A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures
NCT01589692
Pioglitazone in Thyroid Cancers
NCT01655719
Developing a Discrimination Model to Diagnose ALS
NCT01995903
Development of an Insomnia Treatment for Depressed Adolescents
NCT02163564
Correlation of Mesalamine Pharmacokinetics With Local Availability
NCT01999400
Oral Health in Breast Cancer Survivors on Aromatase Inhibitors
NCT01693731
Effects of Direct Transcranial Current Stimulation on Central Neural Pain Processing in Fibromyalgia
NCT01745003
Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children
NCT01554527
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.